Apollo Cancer Centres (ACC), in collaboration with Accuray, a global leader in radiation therapy, has announced the inauguration of India’s inaugural robotic stereotactic radiotherapy program. This pioneering initiative aims to revolutionize oncology care across the Indian sub-continent.

Program Objectives

The program, set to be established at ACC facilities in Chennai and Bangalore, will serve as a hub for advanced education in robotic and stereotactic radiosurgery. It targets radiation oncologists, physicists, therapists, and technologists, offering comprehensive training and hands-on experience with cutting-edge radiation therapy devices.

Strategic Collaboration

Accuray’s expertise in robotic radiosurgery complements Apollo Cancer Centres’ commitment to advancing cancer treatment capabilities. The collaboration aims to elevate the standard of oncological care by introducing state-of-the-art technology and fostering expertise among healthcare professionals.

Impact on Healthcare

This initiative is expected to significantly enhance the treatment options available to cancer patients in India and the broader sub-continent. By promoting the adoption of robotic stereotactic radiotherapy, ACC and Accuray aim to improve treatment precision, reduce treatment times, and enhance patient outcomes.

Educational Opportunities

Participants will engage in immersive learning experiences, including in-depth discussions and practical demonstrations. The program promises to equip healthcare professionals with the skills and knowledge necessary to leverage advanced technologies effectively in clinical practice.

Future Prospects

Looking ahead, the establishment of India’s first robotic stereotactic radiotherapy education centre marks a pivotal milestone in the region’s healthcare landscape. It underscores a shared commitment to innovation and excellence in oncological care, paving the way for future advancements in cancer treatment.

The launch of this program reflects a proactive approach to addressing the evolving needs of cancer care in India. As ACC and Accuray collaborate to empower healthcare professionals, the impact on patient care and treatment outcomes is poised to be transformative.